Landfeldt, Erik https://orcid.org/0000-0002-5758-7151
Abner, Sophia
Pechmann, Astrid
Sejersen, Thomas
McMillan, Hugh J.
Lochmüller, Hanns
Kirschner, Janbernd
Article History
Accepted: 15 September 2022
First Online: 14 December 2022
Declarations
:
: No funding was received for the preparation of this article.
: Thomas Sejersen reports personal fees from PTC Therapeutics, outside the submitted work. Hanns Lochmüller reports grants and personal fees from PTC Therapeutics, outside the submitted work. Erik Landfeldt, Sophia Abner, Astrid Pechmann, Hugh J. McMillan, and Janbernd Kirschner have nothing to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: All data are provided within the article and the Electronic Supplementary Material.
: Not applicable.
: Concept and design: EL, SA, AP, TS, HJM, HL, and JK. Acquisition of data: EL and SA. Analysis and interpretation of data: EL, SA, AP, TS, HKM, HL, and JK. Drafting of the manuscript: EL and SA. Critical revision of the paper for important intellectual content: EL, SA, AP, TS, HJM, HL, and JK.